|
1
|
Stupp R and Roila F; ESMO Guidelines
Working Group, : Malignant glioma: ESMO clinical recommendations
for diagnosis, treatment and follow-up. Ann Oncol. 20 (Suppl
4):S126–S128. 2009. View Article : Google Scholar
|
|
2
|
Meyer MA: Malignant gliomas in adults. N
Engl J Med. 359:18502008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, van den Bent MJ, Mason
WP, Weller M, Mirimanoff RO and Cairncross JG; European
Organisation for Research and Treatment of Cancer Brain Tumor and
Radiotherapy Groups; National Cancer Institute of Canada Clinical
Trials Group, : Changing paradigms-an update on the
multidisciplinary management of malignant glioma. Oncologist.
11:165–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Hottinger AF, van den Bent MJ,
Dietrich PY and Brandes AA: Frequently asked questions in the
medical management of high-grade glioma: A short guide with
practical answers. Ann Oncol. 19 (Suppl 7):vii209–vii216. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buonerba C, Di Lorenzo G, Marinelli A,
Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S
and Sampson JH: A comprehensive outlook on intracerebral therapy of
malignant gliomas. Crit Rev Oncol Hematol. 80:54–68. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sherman JH, Hoes K, Marcus J, Komotar RJ,
Brennan CW and Gutin PH: Neurosurgery for brain tumors: Update on
recent technical advances. Curr Neurol Neurosci Rep. 11:313–319.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kyushiki H, Kuga Y, Suzuki M, Takahashi E
and Horie M: Cloning, expression and mapping of a novel RING-finger
gene (RNF5), a human homologue of a putative zinc-finger gene from
Caenorhabditis elegans. Cytogenet Cell Genet. 79:114–117. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsuda N, Suzuki T, Tanaka K and Nakano
A: Rma1, a novel type of RING finger protein conserved from
Arabidopsis to human, is a membrane-bound ubiquitin ligase.
J Cell Sci. 114:1949–1957. 2001.PubMed/NCBI
|
|
9
|
Younger JM, Chen L, Ren HY, Rosser MF,
Turnbull EL, Fan CY, Patterson C and Cyr DM: Sequential
quality-control checkpoints triage misfolded cystic fibrosis
transmembrane conductance regulator. Cell. 126:571–582. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grove DE, Fan CY, Ren HY and Cyr DM: The
endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate
to facilitate RMA1 E3-dependent degradation of nascent
CFTRDeltaF508. Mol Biol Cell. 22:301–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Didier C, Broday L, Bhoumik A, Israeli S,
Takahashi S, Nakayama K, Thomas SM, Turner CE, Henderson S, Sabe H
and Ronai Z: RNF5, a RING finger protein that regulates cell
motility by targeting paxillin ubiquitination and altered
localization. Mol Cell Biol. 23:5331–5345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong B, Zhang L, Lei C, Li Y, Mao AP,
Yang Y, Wang YY, Zhang XL and Shu HB: The ubiquitin ligase RNF5
regulates antiviral responses by mediating degradation of the
adaptor protein MITA. Immunity. 30:397–407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeon YJ, Khelifa S, Ratnikov B, Scott DA,
Feng Y, Parisi F, Ruller C, Lau E, Kim H, Brill LM, et al:
Regulation of glutamine carrier proteins by RNF5 determines breast
cancer response to ER stress-inducing chemotherapies. Cancer Cell.
27:354–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Han D, Sun L, Huang Q, Gai G, Wu Z,
Meng W and Chen X: PPARα regulates the proliferation of human
glioma cells through miR-214 and E2F2. Biomed Res Int.
2018:38427532018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gravendeel LA, Kouwenhoven MC, Gevaert O,
de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB,
Kloosterhof NK, et al: Intrinsic gene expression profiles of
gliomas are a better predictor of survival than histology. Cancer
Res. 69:9065–9072. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun L, Hui A, Su Q, Vortmeyer A, Kotliarov
Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al:
Neuronal and glioma-derived stem cell factor induces angiogenesis
within the brain. Cancer Cell. 9:287–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta DeltaC(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Tian Q, Wang L, Liu Y, Li B,
Liang Z, Gao P, Zheng K, Zhao B and Lu H: Radiomics strategy for
molecular subtype stratification of lower-grade glioma: Detecting
IDH and TP53 mutations based on multimodal MRI. J Magn Reson
Imaging. 48:916–926. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lehrer S, Rheinstein PH, Green S and
Rosenzweig KE: von Willebrand factor gene expression in primary
lower grade glioma: Mutually Co-occurring mutations in von
Willebrand factor, ATRX, and TP53. Brain Tumor Res Treat. 7:33–38.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Malmer B, Gronberg H, Andersson U, Jonsson
BA and Henriksson R: Microsatellite instability, PTEN and p53
germline mutations in glioma families. Acta Oncol. 40:633–637.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bromberg KD, Kluger HM, Delaunay A, Abbas
S, DiVito KA, Krajewski S and Ronai Z: Increased expression of the
E3 ubiquitin ligase RNF5 is associated with decreased survival in
breast cancer. Cancer Res. 67:8172–8179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi H, Zheng B, Wu Y, Tang Y, Wang L, Gao
Y, Gong H, Du J and Yu R: Ubiquitin ligase Siah1 promotes the
migration and invasion of human glioma cells by regulating HIF-1α
signaling under hypoxia. Oncol Rep. 33:1185–1190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Wang L, Bao H, Zou S, Fu C, Gong H,
Gao Y, Tang Y, Yu R and Shi H: Nrdp1S, short variant of Nrdp1,
inhibits human glioma progression by increasing Nrdp1-mediated
ErbB3 ubiquitination and degradation. J Cell Mol Med. 20:422–429.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi H, Du J, Wang L, Zheng B, Gong H, Wu
Y, Tang Y, Gao Y and Yu R: Lower expression of Nrdp1 in human
glioma contributes tumor progression by reducing apoptosis. IUBMB
Life. 66:704–710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi H, Gong H, Cao K, Zou S, Zhu B, Bao H,
Wu Y, Gao Y, Tang Y and Yu R: Nrdp1-mediated ErbB3 degradation
inhibits glioma cell migration and invasion by reducing cytoplasmic
localization of p27(Kip1). J Neurooncol. 124:357–364. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Runnebaum IB, Nagarajan M, Bowman M, Soto
D and Sukumar S: Mutations in p53 as potential molecular markers
for human breast cancer. Proc Natl Acad Sci USA. 88:10657–10661.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nieves-Neira W and Pommier Y: Apoptotic
response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the
8 human breast cancer cell lines of the NCI Anticancer Drug Screen:
Multifactorial relationships with topoisomerase I, protein kinase
C, Bcl-2, p53, MDM-2 and caspase pathways. Int J Cancer.
82:396–404. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawasoe T, Takeshima H, Yamashita S,
Mizuguchi S, Fukushima T, Yokogami K and Yamasaki K: Detection of
p53 mutations in proliferating vascular cells in glioblastoma
multiforme. J Neurosurg. 122:317–323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marutani M, Tonoki H, Tada M, Takahashi M,
Kashiwazaki H, Hida Y, Hamada J, Asaka M and Moriuchi T:
Dominant-negative mutations of the tumor suppressor p53 relating to
early onset of glioblastoma multiforme. Cancer Res. 59:4765–4769.
1999.PubMed/NCBI
|
|
30
|
Lin C, Liang Y, Zhu H, Zhang J and Zhong
X: R280T mutation of p53 gene promotes proliferation of human
glioma cells through GSK-3β/PTEN pathway. Neurosci Lett. 529:60–65.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Robertson LB, Armstrong GN, Olver BD,
Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R,
Il'yasova D, et al: Survey of familial glioma and role of germline
p16INK4A/p14ARF and p53 mutation. Fam Cancer. 9:413–421. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cui W, Wu R, Cao H, Gao J, Wang X and Ren
Q: P53 gene mutation and expression of MDM2, P53, P16 protein and
their relationship in human glioma. J Huazhong Univ Sci Technolog
Med Sci. 25:622–624, 635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hayashi Y, Yamashita J and Yamaguchi K:
Timing and role of p53 gene mutation in the recurrence of glioma.
Biochem Biophys Res Commun. 180:1145–1150. 1991. View Article : Google Scholar : PubMed/NCBI
|
